{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:54:26Z","timestamp":1768719266594,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["DK20593"],"award-info":[{"award-number":["DK20593"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["DK58404"],"award-info":[{"award-number":["DK58404"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["DK59637"],"award-info":[{"award-number":["DK59637"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["EY08126"],"award-info":[{"award-number":["EY08126"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HD15052"],"award-info":[{"award-number":["HD15052"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA68485"],"award-info":[{"award-number":["P30 CA68485"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R44CA228756"],"award-info":[{"award-number":["R44CA228756"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.canlet.2020.12.023","type":"journal-article","created":{"date-parts":[[2020,12,20]],"date-time":"2020-12-20T22:13:29Z","timestamp":1608502409000},"page":"220-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC"],"prefix":"10.1016","volume":"500","author":[{"given":"Geri","family":"Traver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2930-0739","authenticated-orcid":false,"given":"Konjeti R.","family":"Sekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane S.","family":"Keeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-1124","authenticated-orcid":false,"given":"Michael L.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.12.023_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.6004\/jnccn.2018.0062","article-title":"NCCN guidelines insights: non-small cell lung cancer, version 5.2018","volume":"16","author":"Ettinger","year":"2018","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.canlet.2020.12.023_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrclinonc.2016.79","article-title":"Clinical development of new drug-radiotherapy combinations","volume":"13","author":"Sharma","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2020.12.023_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijrobp.2016.12.037","article-title":"Clinical development of cancer drugs in combination with external beam radiation therapy: US food and drug administration perspective","volume":"98","author":"Walker","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2020.12.023_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.21037\/tlcr.2017.04.02","article-title":"2nd, Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer","volume":"6","author":"Jabbour","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.canlet.2020.12.023_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jtho.2019.10.002","article-title":"Three-year overall survival with durvalumab after chemoradiotherapy in stage III NSCLC-update from PACIFIC","volume":"15","author":"Gray","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.canlet.2020.12.023_bib6","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2020.12.023_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2017.04.006","article-title":"DNA damage in stem cells","volume":"66","author":"Vitale","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2020.12.023_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4331\/wjbc.v6.i3.57","article-title":"DNA damage responses in cancer stem cells: implications for cancer therapeutic strategies","volume":"6","author":"Wang","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.12.023_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2020.12.023_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144885","article-title":"Nucleophosmin in its interaction with ligands","volume":"21","author":"Cela","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2020.12.023_bib11","series-title":"Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non-small Cell Lung Cancer","author":"Li","year":"2020"},{"key":"10.1016\/j.canlet.2020.12.023_bib12","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1158\/1078-0432.CCR-11-1054","article-title":"The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitization","volume":"17","author":"Sekhar","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.023_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1091\/mbc.e13-12-0717","article-title":"Nucleophosmin modulates stability, activity, and nucleolar accumulation of base excision repair proteins","volume":"25","author":"Poletto","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2020.12.023_bib14","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1038\/s41467-019-11795-5","article-title":"hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy","volume":"10","author":"Xu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.12.023_bib15","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1038\/ncomms6437","article-title":"Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin","volume":"5","author":"Ziv","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.12.023_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0092-8674(00)00093-3","article-title":"Nucleophosmin\/B23 is a target of CDK2\/cyclin E in centrosome duplication","volume":"103","author":"Okuda","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.023_bib17","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1073\/pnas.0502978102","article-title":"Sumoylation induced by the Arf tumor suppressor: a p53-independent function","volume":"102","author":"Tago","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.12.023_bib18","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1158\/0008-5472.CAN-10-0382","article-title":"Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates","volume":"70","author":"Koike","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.023_bib19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2014.04.012","article-title":"Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization","volume":"89","author":"Sekhar","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2020.12.023_bib20","doi-asserted-by":"crossref","first-page":"15034","DOI":"10.1038\/celldisc.2015.34","article-title":"A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair","volume":"1","author":"Herr","year":"2015","journal-title":"Cell Discov."},{"key":"10.1016\/j.canlet.2020.12.023_bib21","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bmcl.2009.11.082","article-title":"Novel substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones as potent radio-sensitizing agents","volume":"20","author":"Reddy","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.canlet.2020.12.023_bib22","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1016\/j.bmc.2015.10.019","article-title":"1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: anti-cancer agents that target nucleophosmin 1 (NPM1)","volume":"23","author":"Penthala","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.canlet.2020.12.023_bib23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.radonc.2013.10.040","article-title":"CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells","volume":"110","author":"Desai","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2020.12.023_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.canlet.2020.12.023_bib25","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1128\/JVI.02119-09","article-title":"Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1\/K2 transcription factors","volume":"84","author":"Komorek","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2020.12.023_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.gene.2015.05.065","article-title":"HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution","volume":"569","author":"Stepanenko","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.canlet.2020.12.023_bib27","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1073\/pnas.0701806104","article-title":"Sumoylation of nucleophosmin\/B23 regulates its subcellular localization, mediating cell proliferation and survival","volume":"104","author":"Liu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.12.023_bib28","first-page":"7","article-title":"Control of DNA replication initiation by ubiquitin","author":"Hernandez-Carralero","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2020.12.023_bib29","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1021\/jm201173g","article-title":"Inhibition of homologous recombination in human cells by targeting RAD51 recombinase","volume":"55","author":"Huang","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2020.12.023_bib30","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.0830918100","article-title":"Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses","volume":"100","author":"Rothkamm","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2020.12.023_bib31","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.7150\/thno.15019","article-title":"Standards and methodologies for characterizing radiobiological impact of high-Z nanoparticles","volume":"6","author":"Subiel","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2020.12.023_bib32","series-title":"CompuSyn for Drug Combinations: PC Software and User's Guide: A Computer Program for Quantitation of Synergism and Antagonism in Drug Combinations, and the Determination of IC50 and ED50 and LD50 Values","author":"N","year":"2005"},{"key":"10.1016\/j.canlet.2020.12.023_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-018-0261-5","article-title":"High speed of fork progression induces DNA replication stress and genomic instability","volume":"559","author":"Maya-Mendoza","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.12.023_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.201406099","article-title":"Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells","volume":"208","author":"Zellweger","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2020.12.023_bib35","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1101\/gad.12.18.2956","article-title":"Recovery from DNA replicational stress is the essential function of the S-phase checkpoint pathway","volume":"12","author":"Desany","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2020.12.023_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/09553009514550771","article-title":"The comet moment as a measure of DNA damage in the comet assay","volume":"67","author":"Kent","year":"1995","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.canlet.2020.12.023_bib37","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.bmc.2015.04.018","article-title":"Development and validation of a novel assay to identify radiosensitizers that target nucleophosmin 1","volume":"23","author":"Penthala","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.canlet.2020.12.023_bib38","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1158\/0008-5472.CAN-07-1486","article-title":"Identification of tumorsphere- and tumor-initiating cells in HER2\/Neu-induced mammary tumors","volume":"67","author":"Liu","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.023_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stemcr.2016.12.005","article-title":"RAD51 is a selective DNA repair target to radiosensitize glioma stem cells","volume":"8","author":"King","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.canlet.2020.12.023_bib40","series-title":"Extreme Limiting Dilution Analysis for Comparing Depleted and Enriched Populations in Stem Cell and Other Assays","author":"Hu","year":"2009"},{"key":"10.1016\/j.canlet.2020.12.023_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jim.2009.06.008","article-title":"ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays","volume":"347","author":"Hu","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canlet.2020.12.023_bib42","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.str.2004.09.017","article-title":"The structure and function of Xenopus NO38-core, a histone chaperone in the nucleolus","volume":"12","author":"Namboodiri","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.canlet.2020.12.023_bib43","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.cell.2016.04.047","article-title":"Coexisting liquid phases underlie nucleolar subcompartments","volume":"165","author":"Feric","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.023_bib44","doi-asserted-by":"crossref","first-page":"106646","DOI":"10.1016\/j.jmr.2019.106646","article-title":"NPM1 exhibits structural and dynamic heterogeneity upon phase separation with the p14ARF tumor suppressor","volume":"310","author":"Gibbs","year":"2020","journal-title":"J. Magn. Reson."},{"key":"10.1016\/j.canlet.2020.12.023_bib45","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018101379","article-title":"Phase separation of 53BP1 determines liquid-like behavior of DNA repair compartments","volume":"38","author":"Kilic","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2020.12.023_bib46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/prot.21504","article-title":"Crystal structure of human nucleophosmin-core reveals plasticity of the pentamer-pentamer interface","volume":"69","author":"Lee","year":"2007","journal-title":"Proteins"},{"key":"10.1016\/j.canlet.2020.12.023_bib47","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/onc.2008.54","article-title":"NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells","volume":"27","author":"Qi","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.12.023_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055313","article-title":"Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model","volume":"8","author":"Cun","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.12.023_bib49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1749-6632.1994.tb52834.x","article-title":"Biological responses of human apurinic endonuclease to radiation-induced DNA damage","volume":"726","author":"Chen","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.canlet.2020.12.023_bib50","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/cgt.2008.30","article-title":"Chimeric adenoviral vector Ad5\/F35-mediated APE1 siRNA enhances sensitivity of human colorectal cancer cells to radiotherapy in vitro and in vivo","volume":"15","author":"Xiang","year":"2008","journal-title":"Canc. Gene Ther."},{"key":"10.1016\/j.canlet.2020.12.023_bib51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","article-title":"DNA replication stress as a hallmark of cancer","volume":"10","author":"Macheret","year":"2015","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2020.12.023_bib52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrc3916","article-title":"Replication stress and cancer","volume":"15","author":"Gaillard","year":"2015","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.12.023_bib53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1158\/2159-8290.CD-17-1461","article-title":"Mechanisms of oncogene-induced replication stress: jigsaw falling into place","volume":"8","author":"Kotsantis","year":"2018","journal-title":"Canc. Discov."},{"key":"10.1016\/j.canlet.2020.12.023_bib54","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846263","article-title":"Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments","volume":"19","author":"Liao","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2020.12.023_bib55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jmcb\/mjq049","article-title":"More forks on the road to replication stress recovery","volume":"3","author":"Allen","year":"2011","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2020.12.023_bib56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.molcel.2010.01.021","article-title":"Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair","volume":"37","author":"Petermann","year":"2010","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2020.12.023_bib57","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1038\/s41467-018-06435-3","article-title":"Spatiotemporal dynamics of homologous recombination repair at single collapsed replication forks","volume":"9","author":"Whelan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2020.12.023_bib58","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/emboj.2009.206","article-title":"PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination","volume":"28","author":"Bryant","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2020.12.023_bib59","first-page":"59","article-title":"Effects of inhibitors of DNA strand break repair on HeLa cell radiosensitivity","volume":"44","author":"Ward","year":"1984","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.023_bib60","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/emboj.2009.276","article-title":"ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2","volume":"28","author":"Beucher","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2020.12.023_bib61","unstructured":"NCCN Clinical Practice Guideline in Oncology: NCCN GuidelinesR Non-Small Cell Lung Cancer Version 1. 2021- 25 (2020) (Nov) 2020."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520306832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520306832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:54:59Z","timestamp":1759593299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520306832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":61,"alternative-id":["S0304383520306832"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.12.023","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}